Concepedia

Publication | Open Access

Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

DOIFull Paper Access

32

Citations

18

References

2010

Year

P. Pronzato, Enrico Cortesi, Carin C.D. van der Rijt, Alain Bols, José Andrés Moreno-Nogueira, Carlos Oliveira, Peter Barrett‐Lee, Peter Ostler, R Rosso
The Oncologist

Abstract

Early intervention with epoetin alfa was well tolerated and improved anemia-related PROs in patients with breast cancer receiving myelotoxic chemotherapy.

References

YearCitations

Page 1